GLP-1 also affects your brain, helping you feel full and reducing your appetite after a meal
A published real-world study (Advances in Therapy, 2025) documented mean weight loss of 14.1% for semaglutide and 16.5% for tirzepatide over one year in nearly 10,000 patients on FDA-approved formulations - these research figures are not specific to compounded programs or to WellMedr
GLP-1 slows digestion and reduces appetite
Turner S, Naidoo CA, Usher TJ, Kruger A, Venter C, Laubscher GJ, et al
FAQ Can I take Zepbound every 10 days if I am traveling
Activin A Induces Leiomyoma Cell Proliferation, Extracellular Matrix (ECM) Accumulation and Myofibroblastic Transformation of Myometrial Cells via P38 MAPK